Boya Song

Boya Song has a diverse range of work experience in the field of scientific research and analysis. Boya started their career in 2013 as an Application Scientist at Labtech Group, where they developed various application methods and managed quality control. From 2013 to 2016, they served as an Executive Committee Member at the Chinese American Society for Mass Spectrometry (CASMS), planning and organizing events.

From 2016 to 2017, Boya worked as an R&D Scientist at ARUP Laboratories, developing and validating analytical methods for clinical use. Boya then worked as a Bioanalytical Scientist at Absorption Systems from 2017 to 2019, focusing on method development and optimization for LC-MS/MS assays.

In 2020, Boya joined Exelixis as a Scientist I and later became a Senior Scientist I, analyzing pharmacokinetic aspects of preclinical studies and serving as a bioanalytical representative on interdisciplinary project teams. Boya also developed and executed bioanalytical assays for drugs and metabolites.

Boya then joined Cytokinetics in 2022 as a Research Scientist II, focusing on data analysis and interpretation of pharmacokinetics in preclinical studies. Boya contributed to regulatory submissions and provided key ADME/PK data presentations.

Currently, Boya is working at Loxo@Lilly as a Scientific Lead, but specific details about their responsibilities in this role are not provided.

Boya Song holds a Doctor of Philosophy (Ph.D.) in Analytical Chemistry from the University of Connecticut, which was obtained from 2010 to 2016. Prior to that, Boya obtained a Bachelor of Science (BS) in Chemistry from Sichuan University, completed from 2006 to 2010. Boya also holds additional certifications in the field of Mass Spectrometry from the American Society For Mass Spectrometry (ASMS) and Mass Spectrometry: Applications to the Clinical Lab. The specific months of obtaining these certifications are not provided.